Literature DB >> 2690996

The clinical immunobiology of interleukin-2: potential modified uses for improved cancer treatment.

S D Voss, G Weil-Hillman, J A Hank, J A Sosman, P M Sondel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2690996      PMCID： PMC1807781     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN： 0028-7091


× No keyword cloud information.
  48 in total

Review 1.  New perspectives in cell adhesion: RGD and integrins.

Authors:  E Ruoslahti; M D Pierschbacher
Journal:  Science       Date:  1987-10-23       Impact factor: 47.728

2.  Nonrestricted cytotoxicity mediated by interleukin 2-expanded leukocytes is inhibited by anti-LFA-1 monoclonal antibodies (MoAb) but potentiated by anti-CD3 MoAb.

Authors:  B P Chen; M Malkovsky; J A Hank; P M Sondel
Journal:  Cell Immunol       Date:  1987-12       Impact factor: 4.868

Review 3.  The human interleukin-2 receptor: a molecular and biochemical analysis of structure and function.

Authors:  W C Greene
Journal:  Clin Res       Date:  1987-09

4.  The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells.

Authors:  M Tsudo; C K Goldman; K F Bongiovanni; W C Chan; E F Winton; M Yagita; E A Grimm; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

5.  T11/CD2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules.

Authors:  R E Schmidt; J P Caulfield; J Michon; A Hein; M M Kamada; R P MacDermott; R L Stevens; J Ritz
Journal:  J Immunol       Date:  1988-02-01       Impact factor: 5.422

6.  Intra-lymphatic administration of interleukin-2 (IL-2) in cancer patients: a pilot study.

Authors:  G Pizza; D Viza; C De Vinci; J M Vich i Pascuchi; L Busutti; T Bergami
Journal:  Lymphokine Res       Date:  1988

7.  The in vitro function of lymphocytes from 25 cancer patients receiving four to seven consecutive days of recombinant IL-2.

Authors:  N S Rosenthal; J A Hank; P C Kohler; D Z Minkoff; K H Moore; R Bechhofer; R Hong; B Storer; P M Sondel
Journal:  J Biol Response Mod       Date:  1988-04

8.  Repetitive weekly cycles of recombinant human interleukin-2: responses of renal carcinoma with acceptable toxicity.

Authors:  J A Sosman; P C Kohler; J Hank; K H Moore; R Bechhofer; B Storer; P M Sondel
Journal:  J Natl Cancer Inst       Date:  1988-03-02       Impact factor: 13.506

9.  Clinical and immunological effects of recombinant interleukin 2 given by repetitive weekly cycles to patients with cancer.

Authors:  P M Sondel; P C Kohler; J A Hank; K H Moore; N S Rosenthal; J A Sosman; R Bechhofer; B Storer
Journal:  Cancer Res       Date:  1988-05-01       Impact factor: 12.701

10.  The human interleukin 2 receptor beta chain (p70). Direct identification, partial purification, and patterns of expression on peripheral blood mononuclear cells.

Authors:  M Sharon; J P Siegel; G Tosato; J Yodoi; T L Gerrard; W J Leonard
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307
View more
  55 in total

1.  Unidirectional movement of small RNAs from shoots to roots in interspecific heterografts.

Authors:  Shuai Li; Xutong Wang; Wenying Xu; Tong Liu; Chunmei Cai; Liyang Chen; Chancelor B Clark; Jianxin Ma
Journal:  Nat Plants       Date:  2021-01-15       Impact factor: 15.793

2.  FERONIA restricts Pseudomonas in the rhizosphere microbiome via regulation of reactive oxygen species.

Authors:  Yi Song; Andrew J Wilson; Xue-Cheng Zhang; David Thoms; Reza Sohrabi; Siyu Song; Quentin Geissmann; Yang Liu; Lauren Walgren; Sheng Yang He; Cara H Haney
Journal:  Nat Plants       Date:  2021-05-10       Impact factor: 15.793

Review 3.  Genome-wide and sister chromatid-resolved profiling of protein occupancy in replicated chromatin with ChOR-seq and SCAR-seq.

Authors:  Nataliya Petryk; Nazaret Reverón-Gómez; Cristina González-Aguilera; Maria Dalby; Robin Andersson; Anja Groth
Journal:  Nat Protoc       Date:  2021-08-06       Impact factor: 13.491

4.  Transcriptome analysis of blood for the discovery of sex-related genes in ricefield eel Monopterus albus.

Authors:  Weidong Ding; Liping Cao; Zheming Cao; Xuwen Bing
Journal:  Fish Physiol Biochem       Date:  2020-05-29       Impact factor: 2.794

5.  Mammalian SWI/SNF continuously restores local accessibility to chromatin.

Authors:  Mario Iurlaro; Michael B Stadler; Francesca Masoni; Zainab Jagani; Giorgio G Galli; Dirk Schübeler
Journal:  Nat Genet       Date:  2021-02-08       Impact factor: 38.330

6.  A RUNX-CBFβ-driven enhancer directs the Irf8 dose-dependent lineage choice between DCs and monocytes.

Authors:  Koichi Murakami; Haruka Sasaki; Akira Nishiyama; Daisuke Kurotaki; Wataru Kawase; Tatsuma Ban; Jun Nakabayashi; Satoko Kanzaki; Yoichi Sekita; Hideaki Nakajima; Keiko Ozato; Tohru Kimura; Tomohiko Tamura
Journal:  Nat Immunol       Date:  2021-02-18       Impact factor: 25.606

7.  Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation.

Authors:  Jinghui Song; Yuan Zhuang; Chenxu Zhu; Haowei Meng; Bo Lu; Bingteng Xie; Jinying Peng; Mo Li; Chengqi Yi
Journal:  Nat Chem Biol       Date:  2019-12-09       Impact factor: 15.040

8.  Prostate cancer reactivates developmental epigenomic programs during metastatic progression.

Authors:  Mark M Pomerantz; Xintao Qiu; Yanyun Zhu; David Y Takeda; Wenting Pan; Sylvan C Baca; Alexander Gusev; Keegan D Korthauer; Tesa M Severson; Gavin Ha; Srinivas R Viswanathan; Ji-Heui Seo; Holly M Nguyen; Baohui Zhang; Bogdan Pasaniuc; Claudia Giambartolomei; Sarah A Alaiwi; Connor A Bell; Edward P O'Connor; Matthew S Chabot; David R Stillman; Rosina Lis; Alba Font-Tello; Lewyn Li; Paloma Cejas; Andries M Bergman; Joyce Sanders; Henk G van der Poel; Simon A Gayther; Kate Lawrenson; Marcos A S Fonseca; Jessica Reddy; Rosario I Corona; Gleb Martovetsky; Brian Egan; Toni Choueiri; Leigh Ellis; Isla P Garraway; Gwo-Shu Mary Lee; Eva Corey; Henry W Long; Wilbert Zwart; Matthew L Freedman
Journal:  Nat Genet       Date:  2020-07-20       Impact factor: 38.330

9.  Inhaled interleukin-2 in combination with low-dose systemic interleukin-2 and interferon alpha in patients with pulmonary metastatic renal-cell carcinoma: effectiveness and toxicity of mainly local treatment.

Authors:  E Huland; H Heinzer; H Huland
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

10.  BANP opens chromatin and activates CpG-island-regulated genes.

Authors:  Ralph S Grand; Lukas Burger; Cathrin Gräwe; Alicia K Michael; Luke Isbel; Daniel Hess; Leslie Hoerner; Vytautas Iesmantavicius; Sevi Durdu; Marco Pregnolato; Arnaud R Krebs; Sébastien A Smallwood; Nicolas Thomä; Michiel Vermeulen; Dirk Schübeler
Journal:  Nature       Date:  2021-07-07       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.